Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

10.75
Delayed Data
As of Sep 20
 -0.0588 / -0.54%
Today’s Change
6.10
Today|||52-Week Range
14.75
-7.73%
Year-to-Date
No recent news for Eiger BioPharmaceuticals Inc.

Today’s Trading

Previous close10.81
Today’s open11.10
Day’s range10.65 - 11.10
Volume40,954
Average volume (3 months)73,978
Market cap$90.4M
Dividend yield--
Data as of 09/20/2017

Growth & Valuation

Earnings growth (last year)+71.93%
Earnings growth (this year)+34.69%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.01-0.86%
LPCNLipocine Inc+0.07+1.78%
CEMIChembio Diagnostics ...0.000.00%
MRNSMarinus Pharmaceutic...-0.15-3.48%
Data as of 09/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$1.25
Annual revenue (last year)$0.00
Annual profit (last year)-$47.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Cory
Chief Financial &
Principal Accounting Officer
James H. Welch
Corporate headquarters
Palo Alto, California

Forecasts